Clinical trial
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer…
NCT00446069 · Egalet Ltd, Industry · Completed
Key facts
| NCT number | NCT00446069 |
|---|---|
| Title | A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients |
| Official title | A Double-blind, Randomized, 2-way Cross-over, Phase II, Efficacy Trial in Cancer Patients to Assess the Overall Efficacy, Patient Preference, Morphine Related Side Effect Profile and Safety of the Egalet® Controlled Release Morphine Formulation 30-240 mg Once Daily Compared to MST Continus® 15-120… |
| Lead sponsor | Egalet Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Cancer |
| Intervention type | Drug |
| Interventions | Morphine Sulphate |
| Enrollment | 36 |
| Start date | Aug 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Mar 12, 2007 |
| Last update posted | Aug 29, 2016 |
| Countries | Lithuania, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: